RT @JAMANetworkOpen: Open Access from the JAMA Network: Reclassification of a Variant of Thyroid Carcinoma https://t.co/jlc8h42pQE
RT @JAMANetworkOpen: Open Access from the JAMA Network: Reclassification of a Variant of Thyroid Carcinoma https://t.co/jlc8h42pQE
RT @JAMANetworkOpen: Open Access from the JAMA Network: Reclassification of a Variant of Thyroid Carcinoma https://t.co/jlc8h42pQE
RT @JAMANetworkOpen: Open Access from the JAMA Network: Reclassification of a Variant of Thyroid Carcinoma https://t.co/jlc8h42pQE
Open Access from the JAMA Network: Reclassification of a Variant of Thyroid Carcinoma https://t.co/jlc8h42pQE
Reclassification of a Variant of Thyroid Carcinoma | Endocrinology | JAMA Oncology | The JAMA Network - https://t.co/9mi5sngFEL on @JAMAOnc
RT @ebranre: Reclassification of a Variant of Thyroid Carcinoma https://t.co/yt7cDdQxRX
RT @JAMANetworkOpen: Open Access from the JAMA Network: Reclassification of a Variant of Thyroid Carcinoma https://t.co/ukyc5QzrCT
RT @JAMANetworkOpen: Open Access from the JAMA Network: Reclassification of a Variant of Thyroid Carcinoma https://t.co/ukyc5QzrCT
RT @JAMANetworkOpen: Open Access from the JAMA Network: Reclassification of a Variant of Thyroid Carcinoma https://t.co/ukyc5QzrCT
RT @JAMANetworkOpen: Open Access from the JAMA Network: Reclassification of a Variant of Thyroid Carcinoma https://t.co/ukyc5QzrCT
RT @JAMANetworkOpen: Open Access from the JAMA Network: Reclassification of a Variant of Thyroid Carcinoma https://t.co/ukyc5QzrCT
RT @JAMANetworkOpen: Open Access from the JAMA Network: Reclassification of a Variant of Thyroid Carcinoma https://t.co/ukyc5QzrCT
RT @JAMANetworkOpen: Open Access from the JAMA Network: Reclassification of a Variant of Thyroid Carcinoma https://t.co/ukyc5QzrCT
RT @JAMANetworkOpen: Open Access from the JAMA Network: Reclassification of a Variant of Thyroid Carcinoma https://t.co/ukyc5QzrCT
RT @JAMANetworkOpen: Open Access from the JAMA Network: Reclassification of a Variant of Thyroid Carcinoma https://t.co/ukyc5QzrCT
RT @JAMANetworkOpen: Open Access from the JAMA Network: Reclassification of a Variant of Thyroid Carcinoma https://t.co/ukyc5QzrCT
RT @JAMANetworkOpen: Open Access from the JAMA Network: Reclassification of a Variant of Thyroid Carcinoma https://t.co/ukyc5QzrCT
RT @JAMANetworkOpen: Open Access from the JAMA Network: Reclassification of a Variant of Thyroid Carcinoma https://t.co/ukyc5QzrCT
RT @JAMANetworkOpen: Open Access from the JAMA Network: Reclassification of a Variant of Thyroid Carcinoma https://t.co/ukyc5QzrCT
RT @JAMANetworkOpen: Open Access from the JAMA Network: Reclassification of a Variant of Thyroid Carcinoma https://t.co/ukyc5QzrCT
RT @JAMANetworkOpen: Open Access from the JAMA Network: Reclassification of a Variant of Thyroid Carcinoma https://t.co/ukyc5QzrCT
RT @JAMANetworkOpen: Open Access from the JAMA Network: Reclassification of a Variant of Thyroid Carcinoma https://t.co/ukyc5QzrCT
RT @JAMANetworkOpen: Open Access from the JAMA Network: Reclassification of a Variant of Thyroid Carcinoma https://t.co/ukyc5QzrCT
RT @JAMANetworkOpen: Open Access from the JAMA Network: Reclassification of a Variant of Thyroid Carcinoma https://t.co/ukyc5QzrCT
RT @JAMANetworkOpen: Open Access from the JAMA Network: Reclassification of a Variant of Thyroid Carcinoma https://t.co/ukyc5QzrCT
Open Access from the JAMA Network: Reclassification of a Variant of Thyroid Carcinoma https://t.co/ukyc5QzrCT
RT @marenwhymd: When a #notcancer tumor has its own Twitter handle 😂😂😂 #NIFTP #pathology #entpath https://t.co/5j01EhKqmA
RT @Aiims1742: #Pathologists helped change the nomenclature of at least some of these thyroid "cancers" to NIFTP for this reason. https://…
RT @Sara_Jiang: .@RogueRad Yes, in path we're trying: Thyroid EFVPTC->NIFTP name change https://t.co/kwt6IC1qoK #jacr
RT @PathoPictures: It's official! papillary encapsulated thyroid neoplasm is not malignant #NIFT #NIFTP https://t.co/LTbqv91nKn
#Pathologists helped change the nomenclature of at least some of these thyroid "cancers" to NIFTP for this reason. https://t.co/a7F8ZApZnL https://t.co/etQHB0jPKg
Important 2016 paper by Nikiforov et al to reduce cancer overdx: Reclassification of a Variant of Thyroid Carcinoma https://t.co/mu5qX7IYhU
RT @angelpanizo1: @RikiSotillo @BinXu16 @VijayPatho @tlabiano @headandneckpath @Elainemejia06 @DrFNA @edusqo Nomenclature Revision for Enca…
RT @angelpanizo1: @RikiSotillo @BinXu16 @VijayPatho @tlabiano @headandneckpath @Elainemejia06 @DrFNA @edusqo Nomenclature Revision for Enca…
@RikiSotillo @BinXu16 @VijayPatho @tlabiano @headandneckpath @Elainemejia06 @DrFNA @edusqo Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma https://t.co/LOqz2AuNmw
Nikiforov wrote that one variant of papillary thyroid carcinoma shld B reclassified as noninvasive thyroid neoplasm https://t.co/9VB3GaQjQh
RT @JAMAOto: Reclassification of a Variant of Thyroid Carcinoma - A Paradigm Shift to Reduce Overtreatment of Indolent Tumors https://t.co/…
RT @JAMAOto: Reclassification of a Variant of Thyroid Carcinoma - A Paradigm Shift to Reduce Overtreatment of Indolent Tumors https://t.co/…
RT @JAMAOnc: Reclassification of a Variant of Thyroid Carcinoma - A Paradigm Shift to Reduce Overtreatment of Indolent Tumors https://t.co/…
RT @JAMASurgery: Reclassification of a Variant of Thyroid Carcinoma - A Paradigm Shift to Reduce Overtreatment of Indolent Tumors https://t…
RT @JAMAOto: Reclassification of a Variant of Thyroid Carcinoma - A Paradigm Shift to Reduce Overtreatment of Indolent Tumors https://t.co/…
RT @JAMAOto: Reclassification of a Variant of Thyroid Carcinoma - A Paradigm Shift to Reduce Overtreatment of Indolent Tumors https://t.co/…
RT @JAMAOto: Reclassification of a Variant of Thyroid Carcinoma - A Paradigm Shift to Reduce Overtreatment of Indolent Tumors https://t.co/…
RT @JAMAOnc: Reclassification of a Variant of Thyroid Carcinoma - A Paradigm Shift to Reduce Overtreatment of Indolent Tumors https://t.co/…
RT @JAMASurgery: Reclassification of a Variant of Thyroid Carcinoma - A Paradigm Shift to Reduce Overtreatment of Indolent Tumors https://t…
RT @JAMAOnc: Reclassification of a Variant of Thyroid Carcinoma - A Paradigm Shift to Reduce Overtreatment of Indolent Tumors https://t.co/…
RT @JAMAOnc: Reclassification of a Variant of Thyroid Carcinoma - A Paradigm Shift to Reduce Overtreatment of Indolent Tumors https://t.co/…
RT @JAMASurgery: Reclassification of a Variant of Thyroid Carcinoma - A Paradigm Shift to Reduce Overtreatment of Indolent Tumors https://t…
RT @JAMAOnc: Reclassification of a Variant of Thyroid Carcinoma - A Paradigm Shift to Reduce Overtreatment of Indolent Tumors https://t.co/…
RT @JAMAOnc: Reclassification of a Variant of Thyroid Carcinoma - A Paradigm Shift to Reduce Overtreatment of Indolent Tumors https://t.co/…
RT @JAMASurgery: Reclassification of a Variant of Thyroid Carcinoma - A Paradigm Shift to Reduce Overtreatment of Indolent Tumors https://t…
RT @JAMAOnc: Reclassification of a Variant of Thyroid Carcinoma - A Paradigm Shift to Reduce Overtreatment of Indolent Tumors https://t.co/…
Reclassification of a Variant of Thyroid Carcinoma https://t.co/sluNltgvUp
RT @JAMAOnc: Reclassification of a Variant of Thyroid Carcinoma - A Paradigm Shift to Reduce Overtreatment of Indolent Tumors https://t.co/…
Reclassification of a Variant of Thyroid Carcinoma https://t.co/va1TFMo1kn
RT @JAMAOto: Reclassification of a Variant of Thyroid Carcinoma - A Paradigm Shift to Reduce Overtreatment of Indolent Tumors https://t.co/…
RT @JAMASurgery: Reclassification of a Variant of Thyroid Carcinoma - A Paradigm Shift to Reduce Overtreatment of Indolent Tumors https://t…
RT @JAMAOnc: Reclassification of a Variant of Thyroid Carcinoma - A Paradigm Shift to Reduce Overtreatment of Indolent Tumors https://t.co/…
RT @JAMASurgery: Reclassification of a Variant of Thyroid Carcinoma - A Paradigm Shift to Reduce Overtreatment of Indolent Tumors https://t…
Reclassification of a Variant of Thyroid Carcinoma - A Paradigm Shift to Reduce Overtreatment of Indolent Tumors https://t.co/21zPoYxzTe
Reclassification of a Variant of Thyroid Carcinoma - A Paradigm Shift to Reduce Overtreatment of Indolent Tumors https://t.co/dGdXRP3OrE
Reclassification of a Variant of Thyroid Carcinoma - A Paradigm Shift to Reduce Overtreatment of Indolent Tumors https://t.co/0wglTESyNU
@amuellerml This is the link for the thyroid slides https://t.co/7mL8Z4U8te related study paper https://t.co/BrkXALYYbw
RT @chioseasi: Digital slides of #NIFTP are here: https://t.co/OHmqtMfCxC? #PathJC 8/23 9PM EST https://t.co/k8Rfm6QMjq https://t.co/Slb48L…
RT @chioseasi: Digital slides of #NIFTP are here: https://t.co/OHmqtMfCxC? #PathJC 8/23 9PM EST https://t.co/k8Rfm6QMjq https://t.co/Slb48L…
RT @chioseasi: Digital slides of #NIFTP are here: https://t.co/OHmqtMfCxC? #PathJC 8/23 9PM EST https://t.co/k8Rfm6QMjq https://t.co/Slb48L…
RT @chioseasi: Digital slides of #NIFTP are here: https://t.co/OHmqtMfCxC? #PathJC 8/23 9PM EST https://t.co/k8Rfm6QMjq https://t.co/Slb48L…
RT @chioseasi: Link to virtual slides of the original NIFTP cases https://t.co/7dsdSxRkR3
RT @chioseasi: Link to virtual slides of the original NIFTP cases https://t.co/7dsdSxRkR3
RT @chioseasi: Link to virtual slides of the original NIFTP cases https://t.co/7dsdSxRkR3
RT @chioseasi: Digital slides of #NIFTP are here: https://t.co/OHmqtMfCxC? #PathJC 8/23 9PM EST https://t.co/k8Rfm6QMjq https://t.co/Slb48L…
RT @chioseasi: Link to virtual slides of the original NIFTP cases https://t.co/7dsdSxRkR3
RT @chioseasi: Digital slides of #NIFTP are here: https://t.co/OHmqtMfCxC? #PathJC 8/23 9PM EST https://t.co/k8Rfm6QMjq https://t.co/Slb48L…
RT @chioseasi: Link to virtual slides of the original NIFTP cases https://t.co/7dsdSxRkR3
Link to virtual slides of the original NIFTP cases https://t.co/7dsdSxRkR3
RT @chioseasi: virtual #NIFTP #WSI collection #Pathjc https://t.co/7dsdSxRkR3
"... A Paradigm Shift to Reduce Overtreatment of Indolent Tumors," JAMA Oncol → https://t.co/aDL3s2zzu6 [2/2]
RT @chioseasi: virtual #NIFTP #WSI collection #Pathjc https://t.co/7dsdSxRkR3
RT @chioseasi: virtual #NIFTP #WSI collection #Pathjc https://t.co/7dsdSxRkR3
Retweeted Simon Chiosea, MD (@chioseasi): virtual #NIFTP #WSI collection #Pathjc https://t.co/nfZPYtdfMG https://t.co/5yclKS2Qpy
RT @chioseasi: virtual #NIFTP #WSI collection #Pathjc https://t.co/7dsdSxRkR3
RT @chioseasi: virtual #NIFTP #WSI collection #Pathjc https://t.co/7dsdSxRkR3
RT @chioseasi: virtual #NIFTP #WSI collection #Pathjc https://t.co/7dsdSxRkR3
RT @chioseasi: virtual #NIFTP #WSI collection #Pathjc https://t.co/7dsdSxRkR3
RT @chioseasi: virtual #NIFTP #WSI collection #Pathjc https://t.co/7dsdSxRkR3
RT @chioseasi: virtual #NIFTP #WSI collection #Pathjc https://t.co/7dsdSxRkR3
RT @chioseasi: virtual #NIFTP #WSI collection #Pathjc https://t.co/7dsdSxRkR3
RT @chioseasi: Digital slides of #NIFTP are here: https://t.co/OHmqtMfCxC? #PathJC 8/23 9PM EST https://t.co/k8Rfm6QMjq https://t.co/Slb48L…
RT @chioseasi: Digital slides of #NIFTP are here: https://t.co/OHmqtMfCxC? #PathJC 8/23 9PM EST https://t.co/k8Rfm6QMjq https://t.co/Slb48L…
RT @chioseasi: virtual #NIFTP #WSI collection #Pathjc https://t.co/7dsdSxRkR3
RT @chioseasi: virtual #NIFTP #WSI collection #Pathjc https://t.co/7dsdSxRkR3
RT @chioseasi: virtual #NIFTP #WSI collection #Pathjc https://t.co/7dsdSxRkR3
RT @chioseasi: virtual #NIFTP #WSI collection #Pathjc https://t.co/7dsdSxRkR3
RT @chioseasi: Digital slides of #NIFTP are here: https://t.co/OHmqtMfCxC? #PathJC 8/23 9PM EST https://t.co/k8Rfm6QMjq https://t.co/Slb48L…
RT @chioseasi: virtual #NIFTP #WSI collection #Pathjc https://t.co/7dsdSxRkR3